Pakistan Suspends Trade with India

Pakistan has suspended all trade with India in response to India's decision to suspend the Indus Waters Treaty following a terrorist attack in Pahalgam, Jammu and Kashmir, which killed 26 people. The attack was claimed by The Resistance Front, a proxy of Lashkar-e-Taiba. This trade suspension has triggered emergency preparedness measures by the Pakistan — Drug Regulatory Authority of Pakistan to secure pharmaceutical supplies, as Pakistan relies on India for 30-40% of its pharmaceutical raw materials and finished products. The Pakistan — Drug Regulatory Authority of Pakistan is actively seeking alternative sources from China, Russia, and several European countries to ensure the continuous availability of essential medical supplies. Industry insiders, including Tauqeer-ul-Haq of the Pakistan Pharmaceutical Manufacturers Association, have appealed for an exemption for the pharmaceutical sector from the trade ban, warning of critical shortages. Public health experts like Zafar Iqbal view this crisis as a potential catalyst for Pakistan to invest in local production of Active Pharmaceutical Ingredients, vaccines, and biological products.